Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors—Results from the Swiss IBD Cohort Study

Abstract

IBD patients showed increased risk for lymphoma and biliary cancer, but not colorectal cancer and cancer overall. Age and recent use of immunomodulators were the main risk factors for malignancy, while aminosalicylates and biologics appear to be protective.

References

Page 1

	Year	Citations
Cancer risk in patients with inflammatory bowel disease Çharles N. Bernstein, James Blanchard, Erich V. Kliewer, Cancer	2001	1.2K
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier, The Lancet Lymphoproliferative DisordersGastroenterologyPathologyClinical GastroenterologyUlcerative Colitis	2009	1.1K
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson, Gastroenterology Colonoscopic Surveillance ProgramGastroenterologyDiagnosisPathologyGi Technique	2006	643
Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years Tine Jess, Jacob Simonsen, Kristian Tore Jørgensen, Gastroenterology Surgical OncologyEpidemiologyMedicineClinical EpidemiologyGastroenterology	2012	526
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease Millie D. Long, Christopher F. Martin, Clare A. Pipkin, Gastroenterology Nonmelanoma Skin CancerCancer EpidemiologyMedicineMelanomaGastroenterology	2012	514
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease Laurent Peyrin‐Biroulet, Kiarash Khosrotehrani, Fabrice Carrat, Gastroenterology MedicineNonmelanoma Skin CancersGastroenterologyPathologyDermatology	2011	484
Ursodiol Use Is Associated with Lower Prevalence of Colonic Neoplasia in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis Bruce Y. Tung, Mary J. Emond, Rodger C. Haggitt, Annals of Internal Medicine	2001	467
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis William Connell, John Edward Lennard-Jones, Christopher B. Williams, Gastroenterology MedicineGastroenterologyPathologyGi TechniqueSurgery	1994	456
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies Vito Annese, Laurent Beaugerie, Laurence J. Egan, Journal of Crohn s and Colitis	2015	412
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis BA Lashner, K. Provencher, DL Seidner, Gastroenterology InflammationNutritionClinical NutritionGastroenterologyPathology	1997	298

Page 1